Itaconate shunt hypothesis

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Load video
YouTube
Rob Phair presents the Itaconate Shunt Hypothesis for ME/CFS. Jul 12, 2022

The Itaconate Shunt hypothesis for ME/CFS was devised by Dr Robert Phair, PhD, with Professor Ronald Davis at the Open Medicine Foundation. It builds on earlier findings by McGregor et al. (2019).[1][2]

Theory[edit | edit source]

Evidence[edit | edit source]

Treatment[edit | edit source]

Interviews and videos[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. ↑ "Dr Rob Phair presents the Itaconate Shunt Hypothesis for ME/CFS". YouTube. July 12, 2022.
  2. ↑ McGregor, Neil R.; Armstrong, Christopher W.; Lewis, Donald P.; Gooley, Paul R. (July 4, 2019). "Post-Exertional Malaise Is Associated with Hypermetabolism, Hypoacetylation and Purine Metabolism Deregulation in ME/CFS Cases". Diagnostics. 9 (3): 70. doi:10.3390/diagnostics9030070. ISSN 2075-4418.

Retrieved from "https://me-pedia.org/w/index.php?title=Itaconate_shunt_hypothesis&oldid=227092"